Cargando…
MON-510 Progression of Atypical Femur Stress Fracture after Discontinuation of Bisphosphonate Therapy
Background: The risk of bisphosphonate (BP)-induced atypical femur fracture (AFF) is believed to be markedly reduced following BP discontinuation. In this case, we report development and worsening of incomplete AFF occurring years after BP was discontinued. Clinical Case: A 70-year old woman with os...
Autores principales: | Gu, Kristine, Liu, Jerry, Ettinger, Bruce, Lo, Joan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550738/ http://dx.doi.org/10.1210/js.2019-MON-510 |
Ejemplares similares
-
OR03-4 Atypical Femur Fracture Incidence Increases with Duration of Bisphosphonate Exposure
por: Lo, Joan, et al.
Publicado: (2019) -
MON-356 Atypical Femur Fracture with Denosumab
por: Mirza, Faryal S, et al.
Publicado: (2020) -
SAT-524 Re-hospitalization And Mortality Outcome Following Atypical Femur Fracture
por: Yang, Betsy, et al.
Publicado: (2019) -
SAT-534 How Has Bisphosphonate Prescribing Changed in the Past Decade for Primary Fracture?
por: Yang, Betsy, et al.
Publicado: (2019) -
MON-371 The Case of Dueling Femurs
por: Patel, Richa, et al.
Publicado: (2020)